-
Mashup Score: 1Weniger Schmerzen bei Metastasen in der Wirbelsäule durch Präzisions-Strahlentherapie - 6 day(s) ago
Heftige Schmerzen durch Metastasen in der Wirbelsäule sind bei Krebserkrankungen häufig und nur schwer beherrschbar. Eine am USZ entwickelte Studie wies nun nach, dass eine höher dosierte Präzisionsbestrahlung die Schmerzen wirksamer bekämpft und ohne Schädigung des Rückenmarks eingesetzt werden kann.
Source: www.usz.chCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 93Diagnostic CT-Enabled Planning (DART): Results of a Randomized Trial in Palliative Radiation Therapy - 22 day(s) ago
Using diagnostic computed tomography (dCT) scans instead of CT simulation (CTsim) scans can increase departmental efficiency and reduce patient burden. The goal of the DART trial was to assess the efficacy and acceptability of dCT-based planning workflows with a focus on patient experiences, plan deliverability and adequacy of target coverage, and workflows.
Source: www.redjournal.orgCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 162Dose‐intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trial - 28 day(s) ago
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
Categories: General Medicine News, Oncologists2Tweet-
DOSIS - RCT in pts with painful vertebral mets Hypothesis: improved LC -> durable pain response First randomized trial with 6 mo pain reduction as prim endpoint N=63 pts randomized to SBRT vs conv. RT Significant benefit of SBRT: 69.4% vs. 41.9% (p=0.02) https://t.co/5K6ld5dRKa https://t.co/DEBRULELnS
-
-
Mashup Score: 157
R0 resection and radiation therapy have been associated with improved overall survival (OS) in patients with thymic carcinoma (TC). Here, we analyzed which subgroups of patients derive the greatest benefit from postoperative radiation therapy (PORT).
Source: www.jto.orgCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 157
R0 resection and radiation therapy have been associated with improved overall survival (OS) in patients with thymic carcinoma (TC). Here, we analyzed which subgroups of patients derive the greatest benefit from postoperative radiation therapy (PORT).
Source: www.jto.orgCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 67
Lung cancer is the leading cause of cancer related mortality in the United States [1]. Brain metastases are common in lung cancer with 10 % of patients with advanced non-small cell lung cancer (NSCLC) presenting with synchronous brain metastases and 40 % developing brain metastases at some point in the course of the disease [2]. Historically, patients with brain metastases from NSCLC were treated with whole brain radiation therapy (WBRT), however, more recent retrospective and prospective studies have shown that limited numbers of brain metastases can be treated with stereotactic radiosurgery (SRS) without compromising survival [3,4].
Source: www.thegreenjournal.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 24
In patients with localized prostate cancer, stereotactic body radiation therapy (SBRT) is a standard of care option for patients eligible for radiation therapy [1,2]. Randomized controlled trials have demonstrated that SBRT is non-inferior to conventional fractionated radiotherapy regarding biochemical recurrence free survival and acute toxicity [1,2].
Source: www.ctro.scienceCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 124Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer - 1 month(s) ago
Lung cancer is the leading cause of cancer death worldwide. Non-small cell lung cancer (NSCLC) accounts for approximately 85 % of all lung cancer cases [1]. Approximately 20–40 % of patients with lung cancer have brain metastases (BMs) at diagnosis or during their disease course [2,3]. The overall survival (OS) of patients with BMs is poor [4]. BMs worsen patients’ quality of life more than other metastases such as bone and liver metastases [5]. The risk of BMs is higher in epidermal growth factor receptor (EGFR)-mutant NSCLC than in EGFR wild-type NSCLC [6].
Source: www.lungcancerjournal.infoCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 68Virtual Grand Rounds in Radiation Oncology - 1 month(s) ago
Latest Science – Top Speakers – Interactive Format We proudly present the newly established “Virtual Grand Rounds in Radiation Oncology”.
Source: www.usz.chCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 117Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer - 1 month(s) ago
Lung cancer is the leading cause of cancer death worldwide. Non-small cell lung cancer (NSCLC) accounts for approximately 85 % of all lung cancer cases [1]. Approximately 20–40 % of patients with lung cancer have brain metastases (BMs) at diagnosis or during their disease course [2,3]. The overall survival (OS) of patients with BMs is poor [4]. BMs worsen patients’ quality of life more than other metastases such as bone and liver metastases [5]. The risk of BMs is higher in epidermal growth factor receptor (EGFR)-mutant NSCLC than in EGFR wild-type NSCLC [6].
Source: www.lungcancerjournal.infoCategories: General Medicine News, Oncologists2Tweet
RT @RadOncUSZ: Weniger Schmerzen bei Metastasen in der Wirbelsäule durch Präzisions-Strahlentherapie: https://t.co/VP9Ja99yls @Unispital_…